icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Long-Acting Cabotegravir+Rilpivirine in People with HIV with Obesity (BMI>/= 30 kg/m2): High Durability with Distinct Discontinuation Patterns
 

 
 
  IDSA 2026 October 21-24 Wash DC
 

1025261copy

1025262opy

1025263copy

1025264copy

1025265copy

1025266copy

1025267copy

1025268copy

1025269copy

10252610copy

10252611copy

10252612copy

10252613copy

10252614copy

10252615copy

10252616copy

10252617copy

10252618copy

10252619opy

10252620copy

10252621copy

10252622copy